How will recent developments in obesity management change obesity services

How will recent developments in obesity management change obesity services
Tuesday 23rd November 2021, 19.00 - 20.00

In this webinar Alex Miras and an expert panel will discuss the optimal ways that obesity care should be provided in the UK based on experiences with the tiered system. The webinar will also explore how the introduction of obesity pharmacotherapy could serve as an impetus to improve the care given to patients.

 

 

This is a Novo Nordisk Sponsored meeting

Novo Nordisk has provided sponsorship to the Association of British Clinical Diabetologists (ABCD) to fully fund all costs for the development and delivery of this webinar, including creation, administration, promotion and speaker honoraria. Novo Nordisk has had no influence on the content and full editorial control remains the sole responsibility of ABCD.

 

Speakers

  • Mr. David Hopkins

    Coming soon ..

  • Professor Jennifer Logue

    image of Professor Jennifer Logue

    Jennifer Logue is Professor and Honorary Consultant in Metabolic Medicine, focusing both her research and clinical practice on the treatment of obesity and related metabolic disease. Her work focuses on interventions at the level of the individual with the aim of treating or preventing the complications of obesity. This includes interdisciplinary, mixed methods research to develop complex interventions, and pragmatic, efficient clinical trials utilising health record data. Her clinical work includes cardiovascular risk factor and weight management clinics. She is the Associate Dean for Research for the Faculty of Health and Medicine and Deputy Clinical Director of the NIHR North West Coast Clinical Research Network.

  • Professor Barbara McGowan

    image of Professor Barbara McGowan

    Professor Barbara McGowan is a Consultant Endocrinologist at Guy's and St Thomas' Hospital (GSTT) and Professor in Diabetes and Endocrinology at King’s College London. She was awarded a PhD from Imperial College London for investigating ‘The role of relaxin-3 on energy homeostasis and the hypothalamic-pituitary-axis’ and the role of gut hormones and other neuropeptides in appetite control.
    She is R&D lead for Diabetes and Endocrinology at GSTT and the South London Specialty lead for the Metabolic and Endocrine research network. She leads the obesity bariatric service at GSTT where she manages patients with severe and complex obesity. Her areas of research interest are in gut hormones and appetite control, pharmacotherapy for obesity and remission of type 2 diabetes post-bariatric surgery. She is an investigator for several obesity clinical trials and was awarded an NIHR/RCP/CRN prize in recognition of outstanding research within the NHS.
    Professor McGowan is a SCOPE National fellow, a member of the European Society for Endocrinology Policy and Advocacy Task Force and a member of the RCP Advisory Group on Weight and Health. She chairs the GIRFT/ABCD Obesity Task Force. She has served as Treasurer of the Society for Endocrinology and as a Trustee of the Association for the Study of Obesity.

  • Professor ALEX MIRAS

    image of Professor ALEX MIRAS

    Alex Miras is Professor of Endocrinology at Ulster University. His clinical and research work focus solely on Obesity and type 2 diabetes. He has contributed to the clinical management and research in Obesity over the last 14 years, through his work at a high throughput Obesity Centre. The specialist interests of his research Group are the mechanisms of action of interventions for obesity, focusing on pharmacotherapy, medical devices and obesity surgery.

  • Professor john andrew wass

    Professor of Endocrinology, Oxford University
    Head of the Department of Endocrinology at the Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital Oxford, until 2012.

    Research interests: pituitary tumours, acromegaly, adrenal disease, angiogenesis in endocrinology, genetics of osteoporosis, thyroid disease.

    Chair RCP Group on Weight and Health . Spokesperson on Obesity Royal College of Physicians

    Published over 440 articles, edited different textbooks; Oxford Textbook of Endocrinology (3 editions), Clinical Endocrine Oncology (2 editions), Oxford Handbook of Endocrinology (4 editions)

    President European Federation of Endocrine Societies from 2001-2003
    Chairman Society for Endocrinology 2006-2009
    President American Pituitary Society.

    Awards

    Outstanding Leadership Award, American Endocrine Society 2022

    Outstanding Scholarly Physician Award, American Endocrine Society 2016 (first non-American)

    Lifetime Achievement Award, Pituitary Society (America) 2017

    Geoffrey Harris Prize European Society of Endocrinology 2021

    Academic Vice President Royal College of Physicians 2012-2015.

    Presented acclaimed documentary ‘The Fantastical World of Hormones’ on BBC4, 2016

    Current Getting It Right First Time Endocrine Lead, NHS England, visiting and inspecting all endocrine departments in the UK (127) and doing a national report.

  • Professor John Wilding

    image of Professor John Wilding

    Professor John Wilding leads clinical research into Obesity, Diabetes and Endocrinology at the University of Liverpool, where he has worked since 1996, after training in Southampton and London. His clinical interests focus on caring for people with diabetes and obesity and he leads specialist services for obesity at Aintree University Hospital – designated a Centre for Obesity Management by the European Association for the Study of Obesity.
    John’s research team focusses on developing and evaluating treatments for obesity and diabetes. He has published over 350 papers, chapters and review articles, including clinical trials in diabetes and obesity, studies of adipocyte biology and metabolism.
    He chairs the National Clinical Research Network Metabolic and Endocrine Speciality Group.
    He is a past Chair of the UK Association for the Study of Obesity, a member of the Royal College of Physicians Advisory Group on Nutrition, Weight and Health and past President of the World Obesity Federation.

ABCD Corporate Pharma Sponsors

Gold

  • AstraZeneca UK
  • Boehringer Ingelheim and Lilly Alliance
  • Eli Lilly and Company

Silver

  • A Menarini Farmaceutica Internazionale SRL
  • Sanofi

ABCD Corporate Pump & Device Sponsors

Gold

  • Abbott
  • Dexcom
  • Ypsomed Ltd

Silver

  • Air Liquide Healthcare Ltd
  • Insulet International
  • Medtronic Limited

Contact

Address for correspondence: 
ABCD (Diabetes Care) Ltd, 483 Green Lanes, London, N13 4BS

Telephone: 01675 477602
Email: info@abcd.care

Follow Us

ABCD (Diabetes Care) is a company limited by shares in England and Wales under company number 7270377, whose registered address is 3rd Floor, 56 Wellington Street. Leeds, LS1 2EE  Diabetes Care Trust (ABCD) is a registered charity number 1139057, a company limited by guarantee in England and Wales under company number 74248361,whose registered address is 3rd Floor, 56 Wellington Street. Leeds, LS1 2EE . ABCD (Diabetes Care) Ltd is a wholly owned subsidiary of the Diabetes Care Trust (ABCD) Ltd